Nanomedsyn
Montpellier Cedex 5, FR· latest recorded location
NANOMEDSYN is named on 2 US grants and 3 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 2
- Published applications
- 3
- Inventors
- 14
- Granted in 2026 so far
- 0
- Most recent grant
- 1 Jun 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 2 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Technology areas
Share of 5 documents
Recent patents
- Mesoporous organosilica nanoparticles, production method thereof and uses of same1 Jun 2021US 11,021,496 B2
- Multi-functionalized polysaccharide compounds and use thereof for targeting the cation-independent mannose 6-phosphate receptor19 Jan 2021US 10,894,803 B2
- Bifunctional Compounds Targeting the Cation-Independent Mannose 6- Phosphate Receptor8 May 2025US 2025/0144222 A1
- Mesoporous organosilica nanoparticles, production method thereof and uses of same7 May 2020US 2020/0140466 A1
- Multi-functionalized polysaccharide compounds and use thereof for targeting the cation-independent mannose 6-phosphate receptor20 Sep 2018US 2018/0265534 A1
Most cited
By later US patents